The Occurrence of MACE in Patients With AMI Receiving Pitavastatin/Valsartan Treatment

Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets

NCT05627375 ·Status: RECRUITING ·Phase: PHASE3

Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer

NCT01989845 ·Status: COMPLETED ·Phase: PHASE4

Rivaroxaban ACS Specialist Cohort Event Monitoring Study

NCT02673437 ·Status: COMPLETED

Anti-thrombotic Monotherapy in HeartMate 3 Left Ventricular Assist System (LVAS)

NCT03781258 ·Status: UNKNOWN ·Phase: NA

Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New Anti-thrombotics

NCT01210755 ·Status: COMPLETED ·Phase: PHASE4

Non-interventional, Retrospective Cohort Study to Explore OAC Treatment in Korea

NCT03572972 ·Status: COMPLETED

An Observational Study to Evaluate the Incidence of MACCE According to Time Interval of Taking Medication in Patients With Acute Coronary Syndrome or Cerebral Infarction Who Received DAPT for the Secondary Prevention and Esomezol Cap for the Prevention of Gastrointestinal Bleeding

NCT05487560 ·Status: COMPLETED

Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism in Routine Clinical Practice in Germany

NCT04444804 ·Status: COMPLETED

Long-term Surveillance of Patients With Venous Thromboembolism: a Nationwide Prospective Cohort Study

NCT06073366 ·Status: COMPLETED

Non-Interventional Study on Effectiveness of Elxaban Tab. in Patients With Non-valvular Atrial Fibrillation

NCT04125641 ·Status: UNKNOWN

LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin

NCT00321009 ·Status: COMPLETED ·Phase: NA

Long Term Outcomes of Venous Thromboembolism

NCT02268630 ·Status: UNKNOWN

Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban

NCT03214172 ·Status: COMPLETED

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

NCT04263038 ·Status: RECRUITING ·Phase: PHASE4

Effectiveness And Safety Of Dalteparin In Patients With Acute Coronary Syndromes Without ST Elevations In Clinical Practice

NCT00922766 ·Status: COMPLETED

Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events

NCT02155491 ·Status: COMPLETED

Xarelto Evidence in Real Life of Patients' Preference and Satisfaction Study

NCT02876718 ·Status: COMPLETED

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

NCT02064439 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness and Safety of Different Antithrombotic Therapy for the Treatment of Ventricular Thrombus

NCT05006677 ·Status: UNKNOWN

A Prospective Cohort Study on Warfarin Personalized Medication

NCT06428110 ·Status: COMPLETED

An Observational Post-Authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban (Xarelto®).

NCT01871194 ·Status: COMPLETED

Special Drug Use Investigation of Xarelto for Venous Thromboembolism (VTE)

NCT02558465 ·Status: COMPLETED

Venous Thromboembolism (VTE) Treatment Study in Japanese Pulmonary Embolism (PE) Patients

NCT01516814 ·Status: COMPLETED ·Phase: PHASE3

StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study

NCT02679664 ·Status: UNKNOWN ·Phase: PHASE2

THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS)

NCT05033314 ·Status: TERMINATED ·Phase: PHASE3